Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | SHFS 0.1324 -61.39% | XXII 0.1977 -8.34% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | RBNE 0.19 -2.56% | YFOR 0.2236 -1.58% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | TQQQ 66.29 -0.20% | TSLL 9.76 -1.21% | VZ 44.66 -1.19% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | GRAB 2.79 -2.11% | AIOK 12.02 182.82% | SQQQ 39.68 0.20% | ONDS 6.2 2.99% | LABT 0.31 -36.67% | AAPL 347.725 -0.14% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | IREN 24.905 -2.37% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | NFLX 65.85 -1.79% | QID 14.55 0.14% | CLRO 3.25 69.27% | WULF 11.32 0.00%
IGIGM Biosciences, Inc. logo

IGM Biosciences, Inc. (IGMS)

NASDAQ Global Select · Currency in USD
$1.27 ▲ +0.00 (+0.00%)
At close: Aug 14, 4:00 PM ET. Market closed.

Summary

Previous Close
$1.27
Open
$1.27
Day's Range
$1.27 – $1.27
52 Week Range
$0.92 – $22.50
Volume
1,588,637
Avg. Volume
634,437
Market Cap
$77.50M
Beta (5Y Monthly)
0.59
PE Ratio (TTM)
--
EPS (TTM)
-$3.24
Earnings Date
--
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$16.79

Profile: IGM Biosciences, Inc.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
149
CEO
Mary Beth Harler
Website
igmbio.com

IGM Biosciences, Inc. operates as a biotechnology firm dedicated to advancing Immunoglobulin M (IgM) antibodies. These novel therapeutic agents are being developed for a broad spectrum of conditions, including various cancers, infectious ailments, and autoimmune and inflammatory disorders. The company's most advanced experimental treatment is IGM-2323, a bispecific IgM antibody.

Earnings

DateEst.Actual
Jul 31, 2025-$0.30$1.58Beat
May 13, 2025-$0.41-$0.86Miss
May 6, 2025-$0.45-$0.61Miss
Nov 8, 2024-$0.82-$1.01Miss
Aug 14, 2024-$0.04-$0.79Miss
May 8, 2024-$0.84-$0.83Beat

Analyst view

Consensus price target
$16.79 ▲ +1,222.0%
Range $1.50 – $31.00
Rating: Hold
Buy 44% · Hold 56% · Sell 0%

Get free alerts on IGMS and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.